Pull to refresh
Logo
Daily Brief
Following
Why
Dennis Slamon

Dennis Slamon

American oncologist

Appears in 2 stories

Born: 1948 (age 77 years), New Castle, PA
Awards: Lasker–DeBakey Clinical Medical Research Award and Canada Gairdner International Award

Stories

The long war on breast cancer

New Capabilities

Oncologist and researcher who developed Herceptin - Director, UCLA Clinical/Translational Research

The U.S. breast cancer death rate has fallen 44% since its 1989 peak—an estimated 546,000 lives saved. Susan G. Komen's 2026 Progress Outlook attributes three-quarters of this decline to treatment advances and the remainder to earlier detection through mammography screening.

Updated Feb 3

Therapeutic cancer vaccines emerge from decades of development

New Capabilities

Director, UCLA Jonsson Comprehensive Cancer Center - Continuing HER2 research

Metastatic breast cancer typically kills most patients within five years. A small group of women vaccinated in a Duke University clinical trial two decades ago have defied that prognosis entirely—all remain alive today. Researchers discovered these survivors still carry specialized immune cells capable of recognizing their cancer, pointing to a mechanism that could make therapeutic cancer vaccines work reliably.

Updated Jan 31